CA2197178A1 - Composes de type bicyclolactame; leur emploi et intermediaire pour leur preparation - Google Patents

Composes de type bicyclolactame; leur emploi et intermediaire pour leur preparation

Info

Publication number
CA2197178A1
CA2197178A1 CA002197178A CA2197178A CA2197178A1 CA 2197178 A1 CA2197178 A1 CA 2197178A1 CA 002197178 A CA002197178 A CA 002197178A CA 2197178 A CA2197178 A CA 2197178A CA 2197178 A1 CA2197178 A1 CA 2197178A1
Authority
CA
Canada
Prior art keywords
group
effect
same
benzoyl
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002197178A
Other languages
English (en)
Other versions
CA2197178C (fr
Inventor
Kazuo Ogawa
Ichiro Yamawaki
Manabu Kaneda
Takashi Arima
Junji Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2197178A1 publication Critical patent/CA2197178A1/fr
Application granted granted Critical
Publication of CA2197178C publication Critical patent/CA2197178C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
CA002197178A 1995-06-12 1996-06-07 Composes de type bicyclolactame; leur emploi et intermediaire pour leur preparation Expired - Fee Related CA2197178C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP17032995 1995-06-12
JP7/170329 1995-06-12
JP7/274654 1995-09-27
JP27465495A JP3161948B2 (ja) 1995-06-12 1995-09-27 ビシクロラクタム化合物
PCT/JP1996/001565 WO1996041796A1 (fr) 1995-06-12 1996-06-07 Composes de bicyclolactame, leur emploi et compose intermediaire dans leur production

Publications (2)

Publication Number Publication Date
CA2197178A1 true CA2197178A1 (fr) 1996-12-27
CA2197178C CA2197178C (fr) 2001-05-01

Family

ID=26493354

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002197178A Expired - Fee Related CA2197178C (fr) 1995-06-12 1996-06-07 Composes de type bicyclolactame; leur emploi et intermediaire pour leur preparation

Country Status (10)

Country Link
JP (1) JP3161948B2 (fr)
KR (1) KR100220172B1 (fr)
AT (1) ATE224369T1 (fr)
AU (1) AU697656B2 (fr)
CA (1) CA2197178C (fr)
DE (1) DE69623747T2 (fr)
DK (1) DK0790237T3 (fr)
ES (1) ES2183956T3 (fr)
PT (1) PT790237E (fr)
WO (1) WO1996041796A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991011434A1 (fr) * 1990-02-02 1991-08-08 Taiho Pharmaceutical Company, Limited Derive de bicyclolactame
WO1995026187A1 (fr) * 1994-03-28 1995-10-05 Taiho Pharmaceutical Company, Ltd. Agent anxiolytique

Also Published As

Publication number Publication date
KR970704686A (ko) 1997-09-06
WO1996041796A1 (fr) 1996-12-27
JP3161948B2 (ja) 2001-04-25
AU5911896A (en) 1997-01-09
DE69623747T2 (de) 2003-05-22
AU697656B2 (en) 1998-10-15
DE69623747D1 (de) 2002-10-24
JPH0959251A (ja) 1997-03-04
PT790237E (pt) 2003-02-28
KR100220172B1 (ko) 1999-09-01
ES2183956T3 (es) 2003-04-01
CA2197178C (fr) 2001-05-01
DK0790237T3 (da) 2002-10-14
ATE224369T1 (de) 2002-10-15

Similar Documents

Publication Publication Date Title
BG103785A (en) Pyrrolo[2,3-d]pyrimidines and their application as tyrosine kinase inhibitors
CA2197298A1 (fr) Nouveaux derives de la pyrimidine; methodes de preparation
IL110091A (en) POLYSUBSTITUTED IMIDAZO £4, 5-c| PYRIDIN-4-AMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU7316387A (en) Pyrrole-amidine antitumorals
GR3035414T3 (en) Novel imidazole derivatives, their preparation and therapeutic applications.
AU3688193A (en) 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
AU537028B2 (en) Imidazole derivatives
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
MY123083A (en) Acyclic nucleoside derivatives
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
AU2359392A (en) Dihydropyridine derivatives useful in antitumor therapy
AU3484389A (en) 6-phenyl-3(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives, their preparation and their application in therapy
CA2262997A1 (fr) Produits pharmaceutiques preventifs et curatifs de maladies liees a des defaillances de cellules de l'endothelium vasculaire
MXPA04003278A (es) Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
CA2197178A1 (fr) Composes de type bicyclolactame; leur emploi et intermediaire pour leur preparation
DE3569528D1 (en) Penem derivatives, methods of producing them, their use and pharmaceutical compositions
CA2149170A1 (fr) Agent pour la prevention ou le soulagement des symptomes d'allergie
TW334428B (en) Novel benzodiazepine derivatives
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
AU526978B2 (en) Tetracyclic indole derivatives
IE891261L (en) Heterotetracyclic lactam derivatives
AU4507989A (en) Aryloxy-, arylthio-, heteroaryloxy-, heteroarylthio- alkenylene derivatives of amines
ATE42291T1 (de) Spiro(indolo(1,7-ab>(1,5>benzodiazepin-2,4'piperidine> und zwischenprodukte, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
CA2272136A1 (fr) Derives de pyrasole ayant une activite antagoniste crf

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed